Cargando…

AB189. Prevalence and risk factors of prostate cancer in Chinese men with PSA 4–10 ng/mL underwent TRUS-guided prostate biopsy: the utilization of PAMD score

OBJECTIVE: To elucidate the characteristics and risk factors for positive biopsy outcomes in Chinese patients with prostate specific antigen (PSA) 4–10 ng/mL, and develop a risk-stratification score model. METHODS: The data of 345 patients underwent transrectal ultrasound-guided prostate biopsy betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Dong, Li, Xuesong, Yu, Wei, He, Qun, Xin, Zhongcheng, Zhou, Liqun, Zhao, Chenglin, Wang, Rui, Wang, Huihui, Wang, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Printed Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842724/ http://dx.doi.org/10.21037/tau.2016.s189

Ejemplares similares

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score
por: Fang, Dong, et al.
Publicado: (2015)

AB190. Could magnetic resonance imaging help identify the presence of prostate cancer before initial biopsy? The development of nomogram predicting the outcomes of prostate biopsy in the Chinese population
por: Fang, Dong, et al.
Publicado: (2016)

AB013. The study on the diagnostic value of f/tPSA to the prostate cancer with tPSA greater than 10 ng/mL
por: Li, Yan-Feng, et al.
Publicado: (2016)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

AB133. Xanthogranulomatous prostatitis with benign prostatic hyperplasia: a case report and review of the literature
por: Wang, Anxi
Publicado: (2016)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
por: Lee, Seung Hwan, et al.
Publicado: (2011)

AB125. The correlation of SRSF1 and survivin in prostate cancer
por: Xiao, Bangming, et al.
Publicado: (2016)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

AB263. Ideas from study on pathological large slices of prostate
por: Qu, Yanchun, et al.
Publicado: (2016)

AB077. The expression and clinical significance of α-actinin-1 in prostate cancer and benign prostatic hyperplasia
por: Cao, Feng-Hong
Publicado: (2017)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

AB158. Atorvastatin induces autophagic cell death in prostate cancer cells in vitro
por: He, Zhenhua, et al.
Publicado: (2016)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4–10 ng ml(−1)
por: Tan, Lincoln GL, et al.
Publicado: (2017)

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml(–1)
por: Wang, Cheng, et al.
Publicado: (2021)

AB067. Transurethral endoscopic treatment of benign prostatic hyperplasia
por: Meng, Qingjun, et al.
Publicado: (2017)

AB070. Roles and mechanisms of soybean isoflavones in androgen-independent transformation of prostate cancer
por: Xu, Li, et al.
Publicado: (2017)

AB142. Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal
por: Gao, Jianhua
Publicado: (2016)

AB073. Clinicopathologic characteristics, therapy and outcomes of primary ureteral small cell carcinoma: a case series and systematic review of the literature
por: Zhong, Wenlong, et al.
Publicado: (2017)

AB074. Indications, techniques and outcomes for ileal ureter replacement: a multicenter experience in China
por: Li, Xuesong, et al.
Publicado: (2017)

AB223. A novel surgical management for male infertility secondary to midline prostatic cyst
por: Cheng, Gong, et al.
Publicado: (2016)

AB075. The application of internal suspension technique in retroperitoneal laparoscopic partial nephrectomy for renal ventral tumors
por: Li, Xuesong, et al.
Publicado: (2017)

AB052. ZEB1 promotes vasculogenic mimicry formation in prostate cancer is associated with epithelial-mesenchymal transition
por: Wang, Hua, et al.
Publicado: (2017)

AB205. Open prostatectomy vs. laparoscopic prostatectomy for benign prostatic hyperplasia with large volume prostate: a meta-analysis
por: Chen, H, et al.
Publicado: (2016)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml
por: Sun, Hongmei, et al.
Publicado: (2022)

AB060. Long-term outcome following thulium vaporesection of the prostate
por: Zhang, Zhaocun, et al.
Publicado: (2017)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
por: Chen, Rui, et al.
Publicado: (2015)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5–10.0 ng ml(-1) and 10.1–20.0 ng ml(-1): a multicenter study
por: Lin, Yu-Rong, et al.
Publicado: (2015)

AB053. Labeling of prostate tumor-specific replication-selective oncolytic adenoviruses with radioactive 125I: inhibitory effects on prostate cancer cell
por: Hao, Lin, et al.
Publicado: (2017)

AB262. Expression of vasohibin-1 in prostate cancer and its progress research
por: Zhang, Bo, et al.
Publicado: (2016)

AB177. Clinical and pathological research of prostate cancer with Gleason score 10
por: Yan, Bin, et al.
Publicado: (2016)

AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
por: Xu, Song, et al.
Publicado: (2017)

Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
por: Wu, Qiang, et al.
Publicado: (2021)

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
por: Solomonidou, Nantia, et al.
Publicado: (2023)

Comparison of percentage free PSA, MRI and GaPSMA PET scan for diagnosing cancer prostate in men with PSA between 4 and 20 ng/ml
por: Kumar, Niraj, et al.
Publicado: (2019)

Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis
por: Kim, Young Jung, et al.
Publicado: (2011)

AB067. Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy (RALP) for oligometastatic prostate cancer versus non-oligometastatic prostate cancer: a propensity score matching study
por: Qu, Min, et al.
Publicado: (2018)

Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
por: Kim, Dae Il, et al.
Publicado: (2012)

AB187. Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality
por: Niu, Yuanjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_36p35va09c0q3hu2nka8ar6uaj